Yan Ming's Form 4 filing
Cytek Biosciences, Inc. (CTKB) · filed Nov 21, 2023
- Accession no.
- 0001209191-23-056353
- Filed
- Nov 21, 2023
- Trade date
- Nov 18-20, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $120.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yan MingCIK 0001874041 | Director, Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2023 | Common Stock | MOption exerciseAcquired | +1,981 | – | – | 7,777,943 | Direct | |
| Nov 18, 2023 | Common Stock | FTax withholdingDisposed | −772 | $5.98 | −$4,616.56 | 7,777,171 | Direct | |
| Nov 18, 2023 | Common Stock | MOption exerciseAcquired | +7,363 | – | – | 7,784,534 | Direct | |
| Nov 18, 2023 | Common Stock | FTax withholdingDisposed | −2,431 | $5.98 | −$14,537.38 | 7,782,103 | Direct | |
| Nov 20, 2023 | Common Stock | SSaleDisposed | −20,000 | $6.03 | −$120,600 | 7,762,103 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2023 | Common Stock | MOption exerciseDisposed | −1,981 | $0.00 | $0 | 17,180 | Direct | |
| Nov 18, 2023 | Common Stock | MOption exerciseDisposed | −7,363 | $0.00 | $0 | 98,179 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.